Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LTD | Chief Accounting Officer | Ordinary Shares | 5.18K | $86.2K | $16.65 | May 16, 2024 | Direct |
TEVA PHARMACEUTICAL INDUSTRIES LTD | Chief Accounting Officer | Restricted Share Units | 3.57K | Mar 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | May 15, 2024 | 2 | -$471K | 4 | May 17, 2024 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Mar 5, 2024 | 2 | $0 | 4 | Mar 7, 2024 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Mar 3, 2024 | 5 | $0 | 4 | Mar 5, 2024 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Feb 28, 2024 | 2 | $0 | 4 | Mar 1, 2024 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Feb 1, 2024 | 1 | -$393K | 4 | Feb 5, 2024 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Aug 4, 2023 | 1 | -$19.7K | 4 | Aug 7, 2023 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Mar 3, 2023 | 0 | $0 | 4/A | Aug 7, 2023 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Feb 28, 2023 | 2 | $0 | 4 | Mar 2, 2023 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Mar 4, 2022 | 5 | $0 | 4 | Mar 8, 2022 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Feb 28, 2022 | 4 | $0 | 4 | Mar 2, 2022 | Chief Accounting Officer |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Nov 24, 2021 | 0 | $0 | 3 | Dec 6, 2021 | Chief Accounting Officer |